AddaVax-Adjuvanted Inactivated Vaccine Confers Protection Against Listeria monocytogenes Challenge in Mice
Current Microbiology · 2026
DOI: 10.1007/s00284-026-04758-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, 2026. Verfasst von Ye Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China. Hauptthemen laut MEDLINE: Listeria monocytogenes, Listeriosis, Bacterial Vaccines, Adjuvants, Immunologic. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Agricultural Science and Technology Independent Innovation Funds, Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
Listeria monocytogenes (Lm) is a facultative intracellular pathogen responsible for life-threatening listeriosis, characterized by high mortality rates. Currently, there is no vaccine available for the prevention or treatment of listeriosis. Here, we developed two adjuvanted inactivated vaccines and evaluated their safety, immunogenicity, and protective efficacy. The hypervirulent Lm strain XYSN was inactivated with β-propiolactone (BPL) and formulated with AddaVax or Alum to produce inactivated vaccines (ADIV and ALIV) respectively. Local reactogenicity and histopathological observations revealed no adverse reactions in a murine model. Humoral assays demonstrated both ADIV and ALIV induced higher antibody titers against Lm XYSN, with ADIV eliciting stronger cellular immune responses, as indicated by increased IL-17 and IFN-γ expression in spleen cells. Notably, ADIV conferred 83.3% protection against a lethal challenge with hypervirulent Lm strain, representing a 50% increase compared with the 33.3% protection achieved by ALIV. AddaVax adjuvant not only augmented humoral responses to inactivated bacterial cells but also elicited stronger cellular immune responses compared to Alum adjuvants, resulting in enhanced immune protection. This research offers insights into developing novel inactivated vaccines for listeriosis prevention, particularly beneficial for immunocompromised individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China.
- Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agrifood Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, Jiangsu Province, China.
- MOA of China, Joint International Research Laboratory of Agriculture, Yangzhou, Jiangsu Province, China.
- Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Disease and Zoonoses, Yangzhou, Jiangsu Province, China.
- Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, China. yylan@yzu.edu.cn.
- Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agrifood Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, Jiangsu Province, China. yylan@yzu.…
Förderung
- National Natural Science Foundation of China
- Jiangsu Agricultural Science and Technology Independent Innovation Funds
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Wang, Y., Wu, L., Chen, C., Meng, F., Du, H., Chen, X., Kang, X., Yao, H., Yin, Y., & Jiao, X. (2026). AddaVax-Adjuvanted Inactivated Vaccine Confers Protection Against Listeria monocytogenes Challenge in Mice. Current Microbiology. https://doi.org/10.1007/s00284-026-04758-9
Vancouver
Wang Y, Wu L, Chen C, Meng F, Du H, Chen X, et al. AddaVax-Adjuvanted Inactivated Vaccine Confers Protection Against Listeria monocytogenes Challenge in Mice. Current Microbiology. 2026. doi:10.1007/s00284-026-04758-9
BibTeX
@article{Wang2026,
author = {Wang, Ye and Wu, Lisi and Chen, Chao and Meng, Fanzeng and Du, Hongxiang and Chen, Xiang and Kang, Xilong and Yao, Hao and Yin, Yuelan and Jiao, Xin'an},
title = {AddaVax-Adjuvanted Inactivated Vaccine Confers Protection Against Listeria monocytogenes Challenge in Mice},
journal = {Current Microbiology},
year = {2026},
doi = {10.1007/s00284-026-04758-9}
}
EUVIMED